Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...

Hims & Hers Health (NYSE:HIMS) shares climbed 2% on Wednesday following the announcement of its planned market entry into ...

Viatris Inc. (NASDAQ:VTRS) could make waves in the weight loss and diabetes market, were it to launch generic versions of Novo Nordisk's Ozempic and Wegovy (both contain semaglutide).This article ...

If so, both the generic version and Wegovy would have the same active ingredient: semaglutide. Before its approval of a brand-name drug, the FDA requires that clinical trials demonstrate the new ...

But Novo Nordisk, the company that makes Ozempic, does not sell semaglutide for compounding purposes, and a generic form of the drug approved by the Food and Drug Administration doesn’t exist, a ...

Scientific model of the molecule semaglutide which is the active ingredient in Novo Nordisk’s mega-blockbuster diabetes drug. REUTERS The agency said it prioritizes review of generic versions of ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

Semaglutide — the type 2 diabetes and weight loss medication sold under the brand names Ozempic and Wegovy — can ... Each semaglutide injection pen or vial will have its own expiration date.